img

Global Nicotinamide Riboside Supplements Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Nicotinamide Riboside Supplements Market Insights, Forecast to 2034

Global Nicotinamide Riboside Supplements market is expected to reach to US$ 73 million in 2024, with a positive growth of %, compared with US$ 67 million in 2022. Backed with the increasing demand from downstream industries, Nicotinamide Riboside Supplements industry is evaluated to reach US$ 110.8 million in 2029. The CAGR will be 7.2% during 2024 to 2029.
Globally, Nicotinamide Riboside Supplements key manufacturers include Thorne, Codeage, ProHealth Longevity, ChromaDex, HPN Nutraceuticals, Cytoplan, solodate, Orgabay and Rossylla, etc. Thorne, Codeage, ProHealth Longevity are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Nicotinamide Riboside Supplements were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Nicotinamide Riboside Supplements market and estimated to attract more attentions from industry insiders and investors.
Nicotinamide Riboside Supplements can be divided into Capsule, Liquid and Softgel,, etc. Capsule is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Nicotinamide Riboside Supplements is widely used in various fields, such as Online Sales and Offline Sales, etc. Online Sales provides greatest supports to the Nicotinamide Riboside Supplements industry development. In 2022, global % sales of Nicotinamide Riboside Supplements went into Online Sales filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Nicotinamide Riboside Supplements market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Nicotinamide Riboside Supplements market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Thorne
Codeage
ProHealth Longevity
ChromaDex
HPN Nutraceuticals
Cytoplan
solodate
Orgabay
Rossylla
Life Extension
Aesticum
ProHealth
NOW
Double Wood Supplements
aSquared Nutrition
Segment by Type
Capsule
Liquid
Softgel

Segment by Application


Online Sales
Offline Sales

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Nicotinamide Riboside Supplements plant distribution, commercial date of Nicotinamide Riboside Supplements, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Nicotinamide Riboside Supplements introduction, etc. Nicotinamide Riboside Supplements Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Nicotinamide Riboside Supplements
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Nicotinamide Riboside Supplements Product Introduction
1.2 Market by Type
1.2.1 Global Nicotinamide Riboside Supplements Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Capsule
1.2.3 Liquid
1.2.4 Softgel
1.3 Market by Application
1.3.1 Global Nicotinamide Riboside Supplements Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Nicotinamide Riboside Supplements Sales Estimates and Forecasts 2018-2029
2.2 Global Nicotinamide Riboside Supplements Revenue by Region
2.2.1 Global Nicotinamide Riboside Supplements Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Nicotinamide Riboside Supplements Revenue by Region (2018-2024)
2.2.3 Global Nicotinamide Riboside Supplements Revenue by Region (2024-2029)
2.2.4 Global Nicotinamide Riboside Supplements Revenue Market Share by Region (2018-2029)
2.3 Global Nicotinamide Riboside Supplements Sales Estimates and Forecasts 2018-2029
2.4 Global Nicotinamide Riboside Supplements Sales by Region
2.4.1 Global Nicotinamide Riboside Supplements Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Nicotinamide Riboside Supplements Sales by Region (2018-2024)
2.4.3 Global Nicotinamide Riboside Supplements Sales by Region (2024-2029)
2.4.4 Global Nicotinamide Riboside Supplements Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Nicotinamide Riboside Supplements Sales by Manufacturers
3.1.1 Global Nicotinamide Riboside Supplements Sales by Manufacturers (2018-2024)
3.1.2 Global Nicotinamide Riboside Supplements Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Nicotinamide Riboside Supplements in 2022
3.2 Global Nicotinamide Riboside Supplements Revenue by Manufacturers
3.2.1 Global Nicotinamide Riboside Supplements Revenue by Manufacturers (2018-2024)
3.2.2 Global Nicotinamide Riboside Supplements Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Nicotinamide Riboside Supplements Revenue in 2022
3.3 Global Key Players of Nicotinamide Riboside Supplements, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Nicotinamide Riboside Supplements Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Nicotinamide Riboside Supplements Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Nicotinamide Riboside Supplements, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Nicotinamide Riboside Supplements, Product Offered and Application
3.8 Global Key Manufacturers of Nicotinamide Riboside Supplements, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Nicotinamide Riboside Supplements Sales by Type
4.1.1 Global Nicotinamide Riboside Supplements Historical Sales by Type (2018-2024)
4.1.2 Global Nicotinamide Riboside Supplements Forecasted Sales by Type (2024-2029)
4.1.3 Global Nicotinamide Riboside Supplements Sales Market Share by Type (2018-2029)
4.2 Global Nicotinamide Riboside Supplements Revenue by Type
4.2.1 Global Nicotinamide Riboside Supplements Historical Revenue by Type (2018-2024)
4.2.2 Global Nicotinamide Riboside Supplements Forecasted Revenue by Type (2024-2029)
4.2.3 Global Nicotinamide Riboside Supplements Revenue Market Share by Type (2018-2029)
4.3 Global Nicotinamide Riboside Supplements Price by Type
4.3.1 Global Nicotinamide Riboside Supplements Price by Type (2018-2024)
4.3.2 Global Nicotinamide Riboside Supplements Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Nicotinamide Riboside Supplements Sales by Application
5.1.1 Global Nicotinamide Riboside Supplements Historical Sales by Application (2018-2024)
5.1.2 Global Nicotinamide Riboside Supplements Forecasted Sales by Application (2024-2029)
5.1.3 Global Nicotinamide Riboside Supplements Sales Market Share by Application (2018-2029)
5.2 Global Nicotinamide Riboside Supplements Revenue by Application
5.2.1 Global Nicotinamide Riboside Supplements Historical Revenue by Application (2018-2024)
5.2.2 Global Nicotinamide Riboside Supplements Forecasted Revenue by Application (2024-2029)
5.2.3 Global Nicotinamide Riboside Supplements Revenue Market Share by Application (2018-2029)
5.3 Global Nicotinamide Riboside Supplements Price by Application
5.3.1 Global Nicotinamide Riboside Supplements Price by Application (2018-2024)
5.3.2 Global Nicotinamide Riboside Supplements Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Nicotinamide Riboside Supplements Market Size by Type
6.1.1 US & Canada Nicotinamide Riboside Supplements Sales by Type (2018-2029)
6.1.2 US & Canada Nicotinamide Riboside Supplements Revenue by Type (2018-2029)
6.2 US & Canada Nicotinamide Riboside Supplements Market Size by Application
6.2.1 US & Canada Nicotinamide Riboside Supplements Sales by Application (2018-2029)
6.2.2 US & Canada Nicotinamide Riboside Supplements Revenue by Application (2018-2029)
6.3 US & Canada Nicotinamide Riboside Supplements Market Size by Country
6.3.1 US & Canada Nicotinamide Riboside Supplements Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Nicotinamide Riboside Supplements Sales by Country (2018-2029)
6.3.3 US & Canada Nicotinamide Riboside Supplements Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Nicotinamide Riboside Supplements Market Size by Type
7.1.1 Europe Nicotinamide Riboside Supplements Sales by Type (2018-2029)
7.1.2 Europe Nicotinamide Riboside Supplements Revenue by Type (2018-2029)
7.2 Europe Nicotinamide Riboside Supplements Market Size by Application
7.2.1 Europe Nicotinamide Riboside Supplements Sales by Application (2018-2029)
7.2.2 Europe Nicotinamide Riboside Supplements Revenue by Application (2018-2029)
7.3 Europe Nicotinamide Riboside Supplements Market Size by Country
7.3.1 Europe Nicotinamide Riboside Supplements Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Nicotinamide Riboside Supplements Sales by Country (2018-2029)
7.3.3 Europe Nicotinamide Riboside Supplements Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Nicotinamide Riboside Supplements Market Size
8.1.1 China Nicotinamide Riboside Supplements Sales (2018-2029)
8.1.2 China Nicotinamide Riboside Supplements Revenue (2018-2029)
8.2 China Nicotinamide Riboside Supplements Market Size by Application
8.2.1 China Nicotinamide Riboside Supplements Sales by Application (2018-2029)
8.2.2 China Nicotinamide Riboside Supplements Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Nicotinamide Riboside Supplements Market Size by Type
9.1.1 Asia Nicotinamide Riboside Supplements Sales by Type (2018-2029)
9.1.2 Asia Nicotinamide Riboside Supplements Revenue by Type (2018-2029)
9.2 Asia Nicotinamide Riboside Supplements Market Size by Application
9.2.1 Asia Nicotinamide Riboside Supplements Sales by Application (2018-2029)
9.2.2 Asia Nicotinamide Riboside Supplements Revenue by Application (2018-2029)
9.3 Asia Nicotinamide Riboside Supplements Sales by Region
9.3.1 Asia Nicotinamide Riboside Supplements Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Nicotinamide Riboside Supplements Revenue by Region (2018-2029)
9.3.3 Asia Nicotinamide Riboside Supplements Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Nicotinamide Riboside Supplements Market Size by Type
10.1.1 Middle East, Africa and Latin America Nicotinamide Riboside Supplements Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Nicotinamide Riboside Supplements Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Nicotinamide Riboside Supplements Market Size by Application
10.2.1 Middle East, Africa and Latin America Nicotinamide Riboside Supplements Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Nicotinamide Riboside Supplements Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Nicotinamide Riboside Supplements Sales by Country
10.3.1 Middle East, Africa and Latin America Nicotinamide Riboside Supplements Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Nicotinamide Riboside Supplements Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Nicotinamide Riboside Supplements Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Thorne
11.1.1 Thorne Company Information
11.1.2 Thorne Overview
11.1.3 Thorne Nicotinamide Riboside Supplements Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Thorne Nicotinamide Riboside Supplements Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Thorne Recent Developments
11.2 Codeage
11.2.1 Codeage Company Information
11.2.2 Codeage Overview
11.2.3 Codeage Nicotinamide Riboside Supplements Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Codeage Nicotinamide Riboside Supplements Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Codeage Recent Developments
11.3 ProHealth Longevity
11.3.1 ProHealth Longevity Company Information
11.3.2 ProHealth Longevity Overview
11.3.3 ProHealth Longevity Nicotinamide Riboside Supplements Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 ProHealth Longevity Nicotinamide Riboside Supplements Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 ProHealth Longevity Recent Developments
11.4 ChromaDex
11.4.1 ChromaDex Company Information
11.4.2 ChromaDex Overview
11.4.3 ChromaDex Nicotinamide Riboside Supplements Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 ChromaDex Nicotinamide Riboside Supplements Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 ChromaDex Recent Developments
11.5 HPN Nutraceuticals
11.5.1 HPN Nutraceuticals Company Information
11.5.2 HPN Nutraceuticals Overview
11.5.3 HPN Nutraceuticals Nicotinamide Riboside Supplements Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 HPN Nutraceuticals Nicotinamide Riboside Supplements Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 HPN Nutraceuticals Recent Developments
11.6 Cytoplan
11.6.1 Cytoplan Company Information
11.6.2 Cytoplan Overview
11.6.3 Cytoplan Nicotinamide Riboside Supplements Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Cytoplan Nicotinamide Riboside Supplements Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Cytoplan Recent Developments
11.7 solodate
11.7.1 solodate Company Information
11.7.2 solodate Overview
11.7.3 solodate Nicotinamide Riboside Supplements Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 solodate Nicotinamide Riboside Supplements Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 solodate Recent Developments
11.8 Orgabay
11.8.1 Orgabay Company Information
11.8.2 Orgabay Overview
11.8.3 Orgabay Nicotinamide Riboside Supplements Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Orgabay Nicotinamide Riboside Supplements Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Orgabay Recent Developments
11.9 Rossylla
11.9.1 Rossylla Company Information
11.9.2 Rossylla Overview
11.9.3 Rossylla Nicotinamide Riboside Supplements Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Rossylla Nicotinamide Riboside Supplements Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Rossylla Recent Developments
11.10 Life Extension
11.10.1 Life Extension Company Information
11.10.2 Life Extension Overview
11.10.3 Life Extension Nicotinamide Riboside Supplements Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Life Extension Nicotinamide Riboside Supplements Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Life Extension Recent Developments
11.11 Aesticum
11.11.1 Aesticum Company Information
11.11.2 Aesticum Overview
11.11.3 Aesticum Nicotinamide Riboside Supplements Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Aesticum Nicotinamide Riboside Supplements Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Aesticum Recent Developments
11.12 ProHealth
11.12.1 ProHealth Company Information
11.12.2 ProHealth Overview
11.12.3 ProHealth Nicotinamide Riboside Supplements Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 ProHealth Nicotinamide Riboside Supplements Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 ProHealth Recent Developments
11.13 NOW
11.13.1 NOW Company Information
11.13.2 NOW Overview
11.13.3 NOW Nicotinamide Riboside Supplements Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 NOW Nicotinamide Riboside Supplements Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 NOW Recent Developments
11.14 Double Wood Supplements
11.14.1 Double Wood Supplements Company Information
11.14.2 Double Wood Supplements Overview
11.14.3 Double Wood Supplements Nicotinamide Riboside Supplements Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Double Wood Supplements Nicotinamide Riboside Supplements Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Double Wood Supplements Recent Developments
11.15 aSquared Nutrition
11.15.1 aSquared Nutrition Company Information
11.15.2 aSquared Nutrition Overview
11.15.3 aSquared Nutrition Nicotinamide Riboside Supplements Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 aSquared Nutrition Nicotinamide Riboside Supplements Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 aSquared Nutrition Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Nicotinamide Riboside Supplements Industry Chain Analysis
12.2 Nicotinamide Riboside Supplements Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Nicotinamide Riboside Supplements Production Mode & Process
12.4 Nicotinamide Riboside Supplements Sales and Marketing
12.4.1 Nicotinamide Riboside Supplements Sales Channels
12.4.2 Nicotinamide Riboside Supplements Distributors
12.5 Nicotinamide Riboside Supplements Customers
13 Market Dynamics
13.1 Nicotinamide Riboside Supplements Industry Trends
13.2 Nicotinamide Riboside Supplements Market Drivers
13.3 Nicotinamide Riboside Supplements Market Challenges
13.4 Nicotinamide Riboside Supplements Market Restraints
14 Key Findings in The Global Nicotinamide Riboside Supplements Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Nicotinamide Riboside Supplements Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Capsule
Table 3. Major Manufacturers of Liquid
Table 4. Major Manufacturers of Softgel
Table 5. Global Nicotinamide Riboside Supplements Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Nicotinamide Riboside Supplements Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Nicotinamide Riboside Supplements Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global Nicotinamide Riboside Supplements Revenue by Region (2024-2029) & (US$ Million)
Table 9. Global Nicotinamide Riboside Supplements Revenue Market Share by Region (2018-2024)
Table 10. Global Nicotinamide Riboside Supplements Revenue Market Share by Region (2024-2029)
Table 11. Global Nicotinamide Riboside Supplements Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global Nicotinamide Riboside Supplements Sales by Region (2018-2024) & (K Units)
Table 13. Global Nicotinamide Riboside Supplements Sales by Region (2024-2029) & (K Units)
Table 14. Global Nicotinamide Riboside Supplements Sales Market Share by Region (2018-2024)
Table 15. Global Nicotinamide Riboside Supplements Sales Market Share by Region (2024-2029)
Table 16. Global Nicotinamide Riboside Supplements Sales by Manufacturers (2018-2024) & (K Units)
Table 17. Global Nicotinamide Riboside Supplements Sales Share by Manufacturers (2018-2024)
Table 18. Global Nicotinamide Riboside Supplements Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 19. Global Nicotinamide Riboside Supplements Revenue Share by Manufacturers (2018-2024)
Table 20. Global Key Players of Nicotinamide Riboside Supplements, Industry Ranking, 2021 VS 2022 VS 2024
Table 21. Nicotinamide Riboside Supplements Price by Manufacturers 2018-2024 (US$/Unit)
Table 22. Global Nicotinamide Riboside Supplements Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Nicotinamide Riboside Supplements by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nicotinamide Riboside Supplements as of 2022)
Table 24. Global Key Manufacturers of Nicotinamide Riboside Supplements, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Nicotinamide Riboside Supplements, Product Offered and Application
Table 26. Global Key Manufacturers of Nicotinamide Riboside Supplements, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Nicotinamide Riboside Supplements Sales by Type (2018-2024) & (K Units)
Table 29. Global Nicotinamide Riboside Supplements Sales by Type (2024-2029) & (K Units)
Table 30. Global Nicotinamide Riboside Supplements Sales Share by Type (2018-2024)
Table 31. Global Nicotinamide Riboside Supplements Sales Share by Type (2024-2029)
Table 32. Global Nicotinamide Riboside Supplements Revenue by Type (2018-2024) & (US$ Million)
Table 33. Global Nicotinamide Riboside Supplements Revenue by Type (2024-2029) & (US$ Million)
Table 34. Global Nicotinamide Riboside Supplements Revenue Share by Type (2018-2024)
Table 35. Global Nicotinamide Riboside Supplements Revenue Share by Type (2024-2029)
Table 36. Nicotinamide Riboside Supplements Price by Type (2018-2024) & (US$/Unit)
Table 37. Global Nicotinamide Riboside Supplements Price Forecast by Type (2024-2029) & (US$/Unit)
Table 38. Global Nicotinamide Riboside Supplements Sales by Application (2018-2024) & (K Units)
Table 39. Global Nicotinamide Riboside Supplements Sales by Application (2024-2029) & (K Units)
Table 40. Global Nicotinamide Riboside Supplements Sales Share by Application (2018-2024)
Table 41. Global Nicotinamide Riboside Supplements Sales Share by Application (2024-2029)
Table 42. Global Nicotinamide Riboside Supplements Revenue by Application (2018-2024) & (US$ Million)
Table 43. Global Nicotinamide Riboside Supplements Revenue by Application (2024-2029) & (US$ Million)
Table 44. Global Nicotinamide Riboside Supplements Revenue Share by Application (2018-2024)
Table 45. Global Nicotinamide Riboside Supplements Revenue Share by Application (2024-2029)
Table 46. Nicotinamide Riboside Supplements Price by Application (2018-2024) & (US$/Unit)
Table 47. Global Nicotinamide Riboside Supplements Price Forecast by Application (2024-2029) & (US$/Unit)
Table 48. US & Canada Nicotinamide Riboside Supplements Sales by Type (2018-2024) & (K Units)
Table 49. US & Canada Nicotinamide Riboside Supplements Sales by Type (2024-2029) & (K Units)
Table 50. US & Canada Nicotinamide Riboside Supplements Revenue by Type (2018-2024) & (US$ Million)
Table 51. US & Canada Nicotinamide Riboside Supplements Revenue by Type (2024-2029) & (US$ Million)
Table 52. US & Canada Nicotinamide Riboside Supplements Sales by Application (2018-2024) & (K Units)
Table 53. US & Canada Nicotinamide Riboside Supplements Sales by Application (2024-2029) & (K Units)
Table 54. US & Canada Nicotinamide Riboside Supplements Revenue by Application (2018-2024) & (US$ Million)
Table 55. US & Canada Nicotinamide Riboside Supplements Revenue by Application (2024-2029) & (US$ Million)
Table 56. US & Canada Nicotinamide Riboside Supplements Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 57. US & Canada Nicotinamide Riboside Supplements Revenue by Country (2018-2024) & (US$ Million)
Table 58. US & Canada Nicotinamide Riboside Supplements Revenue by Country (2024-2029) & (US$ Million)
Table 59. US & Canada Nicotinamide Riboside Supplements Sales by Country (2018-2024) & (K Units)
Table 60. US & Canada Nicotinamide Riboside Supplements Sales by Country (2024-2029) & (K Units)
Table 61. Europe Nicotinamide Riboside Supplements Sales by Type (2018-2024) & (K Units)
Table 62. Europe Nicotinamide Riboside Supplements Sales by Type (2024-2029) & (K Units)
Table 63. Europe Nicotinamide Riboside Supplements Revenue by Type (2018-2024) & (US$ Million)
Table 64. Europe Nicotinamide Riboside Supplements Revenue by Type (2024-2029) & (US$ Million)
Table 65. Europe Nicotinamide Riboside Supplements Sales by Application (2018-2024) & (K Units)
Table 66. Europe Nicotinamide Riboside Supplements Sales by Application (2024-2029) & (K Units)
Table 67. Europe Nicotinamide Riboside Supplements Revenue by Application (2018-2024) & (US$ Million)
Table 68. Europe Nicotinamide Riboside Supplements Revenue by Application (2024-2029) & (US$ Million)
Table 69. Europe Nicotinamide Riboside Supplements Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 70. Europe Nicotinamide Riboside Supplements Revenue by Country (2018-2024) & (US$ Million)
Table 71. Europe Nicotinamide Riboside Supplements Revenue by Country (2024-2029) & (US$ Million)
Table 72. Europe Nicotinamide Riboside Supplements Sales by Country (2018-2024) & (K Units)
Table 73. Europe Nicotinamide Riboside Supplements Sales by Country (2024-2029) & (K Units)
Table 74. China Nicotinamide Riboside Supplements Sales by Type (2018-2024) & (K Units)
Table 75. China Nicotinamide Riboside Supplements Sales by Type (2024-2029) & (K Units)
Table 76. China Nicotinamide Riboside Supplements Revenue by Type (2018-2024) & (US$ Million)
Table 77. China Nicotinamide Riboside Supplements Revenue by Type (2024-2029) & (US$ Million)
Table 78. China Nicotinamide Riboside Supplements Sales by Application (2018-2024) & (K Units)
Table 79. China Nicotinamide Riboside Supplements Sales by Application (2024-2029) & (K Units)
Table 80. China Nicotinamide Riboside Supplements Revenue by Application (2018-2024) & (US$ Million)
Table 81. China Nicotinamide Riboside Supplements Revenue by Application (2024-2029) & (US$ Million)
Table 82. Asia Nicotinamide Riboside Supplements Sales by Type (2018-2024) & (K Units)
Table 83. Asia Nicotinamide Riboside Supplements Sales by Type (2024-2029) & (K Units)
Table 84. Asia Nicotinamide Riboside Supplements Revenue by Type (2018-2024) & (US$ Million)
Table 85. Asia Nicotinamide Riboside Supplements Revenue by Type (2024-2029) & (US$ Million)
Table 86. Asia Nicotinamide Riboside Supplements Sales by Application (2018-2024) & (K Units)
Table 87. Asia Nicotinamide Riboside Supplements Sales by Application (2024-2029) & (K Units)
Table 88. Asia Nicotinamide Riboside Supplements Revenue by Application (2018-2024) & (US$ Million)
Table 89. Asia Nicotinamide Riboside Supplements Revenue by Application (2024-2029) & (US$ Million)
Table 90. Asia Nicotinamide Riboside Supplements Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia Nicotinamide Riboside Supplements Revenue by Region (2018-2024) & (US$ Million)
Table 92. Asia Nicotinamide Riboside Supplements Revenue by Region (2024-2029) & (US$ Million)
Table 93. Asia Nicotinamide Riboside Supplements Sales by Region (2018-2024) & (K Units)
Table 94. Asia Nicotinamide Riboside Supplements Sales by Region (2024-2029) & (K Units)
Table 95. Middle East, Africa and Latin America Nicotinamide Riboside Supplements Sales by Type (2018-2024) & (K Units)
Table 96. Middle East, Africa and Latin America Nicotinamide Riboside Supplements Sales by Type (2024-2029) & (K Units)
Table 97. Middle East, Africa and Latin America Nicotinamide Riboside Supplements Revenue by Type (2018-2024) & (US$ Million)
Table 98. Middle East, Africa and Latin America Nicotinamide Riboside Supplements Revenue by Type (2024-2029) & (US$ Million)
Table 99. Middle East, Africa and Latin America Nicotinamide Riboside Supplements Sales by Application (2018-2024) & (K Units)
Table 100. Middle East, Africa and Latin America Nicotinamide Riboside Supplements Sales by Application (2024-2029) & (K Units)
Table 101. Middle East, Africa and Latin America Nicotinamide Riboside Supplements Revenue by Application (2018-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Nicotinamide Riboside Supplements Revenue by Application (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America Nicotinamide Riboside Supplements Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 104. Middle East, Africa and Latin America Nicotinamide Riboside Supplements Revenue by Country (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Nicotinamide Riboside Supplements Revenue by Country (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Nicotinamide Riboside Supplements Sales by Country (2018-2024) & (K Units)
Table 107. Middle East, Africa and Latin America Nicotinamide Riboside Supplements Sales by Country (2024-2029) & (K Units)
Table 108. Thorne Company Information
Table 109. Thorne Description and Major Businesses
Table 110. Thorne Nicotinamide Riboside Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 111. Thorne Nicotinamide Riboside Supplements Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Thorne Recent Developments
Table 113. Codeage Company Information
Table 114. Codeage Description and Major Businesses
Table 115. Codeage Nicotinamide Riboside Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 116. Codeage Nicotinamide Riboside Supplements Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Codeage Recent Developments
Table 118. ProHealth Longevity Company Information
Table 119. ProHealth Longevity Description and Major Businesses
Table 120. ProHealth Longevity Nicotinamide Riboside Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 121. ProHealth Longevity Nicotinamide Riboside Supplements Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. ProHealth Longevity Recent Developments
Table 123. ChromaDex Company Information
Table 124. ChromaDex Description and Major Businesses
Table 125. ChromaDex Nicotinamide Riboside Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 126. ChromaDex Nicotinamide Riboside Supplements Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. ChromaDex Recent Developments
Table 128. HPN Nutraceuticals Company Information
Table 129. HPN Nutraceuticals Description and Major Businesses
Table 130. HPN Nutraceuticals Nicotinamide Riboside Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 131. HPN Nutraceuticals Nicotinamide Riboside Supplements Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. HPN Nutraceuticals Recent Developments
Table 133. Cytoplan Company Information
Table 134. Cytoplan Description and Major Businesses
Table 135. Cytoplan Nicotinamide Riboside Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 136. Cytoplan Nicotinamide Riboside Supplements Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Cytoplan Recent Developments
Table 138. solodate Company Information
Table 139. solodate Description and Major Businesses
Table 140. solodate Nicotinamide Riboside Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 141. solodate Nicotinamide Riboside Supplements Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. solodate Recent Developments
Table 143. Orgabay Company Information
Table 144. Orgabay Description and Major Businesses
Table 145. Orgabay Nicotinamide Riboside Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 146. Orgabay Nicotinamide Riboside Supplements Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Orgabay Recent Developments
Table 148. Rossylla Company Information
Table 149. Rossylla Description and Major Businesses
Table 150. Rossylla Nicotinamide Riboside Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 151. Rossylla Nicotinamide Riboside Supplements Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Rossylla Recent Developments
Table 153. Life Extension Company Information
Table 154. Life Extension Description and Major Businesses
Table 155. Life Extension Nicotinamide Riboside Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 156. Life Extension Nicotinamide Riboside Supplements Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Life Extension Recent Developments
Table 158. Aesticum Company Information
Table 159. Aesticum Description and Major Businesses
Table 160. Aesticum Nicotinamide Riboside Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 161. Aesticum Nicotinamide Riboside Supplements Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. Aesticum Recent Developments
Table 163. ProHealth Company Information
Table 164. ProHealth Description and Major Businesses
Table 165. ProHealth Nicotinamide Riboside Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 166. ProHealth Nicotinamide Riboside Supplements Product Model Numbers, Pictures, Descriptions and Specifications
Table 167. ProHealth Recent Developments
Table 168. NOW Company Information
Table 169. NOW Description and Major Businesses
Table 170. NOW Nicotinamide Riboside Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 171. NOW Nicotinamide Riboside Supplements Product Model Numbers, Pictures, Descriptions and Specifications
Table 172. NOW Recent Developments
Table 173. Double Wood Supplements Company Information
Table 174. Double Wood Supplements Description and Major Businesses
Table 175. Double Wood Supplements Nicotinamide Riboside Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 176. Double Wood Supplements Nicotinamide Riboside Supplements Product Model Numbers, Pictures, Descriptions and Specifications
Table 177. Double Wood Supplements Recent Developments
Table 178. aSquared Nutrition Company Information
Table 179. aSquared Nutrition Description and Major Businesses
Table 180. aSquared Nutrition Nicotinamide Riboside Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 181. aSquared Nutrition Nicotinamide Riboside Supplements Product Model Numbers, Pictures, Descriptions and Specifications
Table 182. aSquared Nutrition Recent Developments
Table 183. Key Raw Materials Lists
Table 184. Raw Materials Key Suppliers Lists
Table 185. Nicotinamide Riboside Supplements Distributors List
Table 186. Nicotinamide Riboside Supplements Customers List
Table 187. Nicotinamide Riboside Supplements Market Trends
Table 188. Nicotinamide Riboside Supplements Market Drivers
Table 189. Nicotinamide Riboside Supplements Market Challenges
Table 190. Nicotinamide Riboside Supplements Market Restraints
Table 191. Research Programs/Design for This Report
Table 192. Key Data Information from Secondary Sources
Table 193. Key Data Information from Primary Sources
List of Figures
Figure 1. Nicotinamide Riboside Supplements Product Picture
Figure 2. Global Nicotinamide Riboside Supplements Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Nicotinamide Riboside Supplements Market Share by Type in 2022 & 2029
Figure 4. Capsule Product Picture
Figure 5. Liquid Product Picture
Figure 6. Softgel Product Picture
Figure 7. Global Nicotinamide Riboside Supplements Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Nicotinamide Riboside Supplements Market Share by Application in 2022 & 2029
Figure 9. Online Sales
Figure 10. Offline Sales
Figure 11. Nicotinamide Riboside Supplements Report Years Considered
Figure 12. Global Nicotinamide Riboside Supplements Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Nicotinamide Riboside Supplements Revenue 2018-2029 (US$ Million)
Figure 14. Global Nicotinamide Riboside Supplements Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Nicotinamide Riboside Supplements Revenue Market Share by Region (2018-2029)
Figure 16. Global Nicotinamide Riboside Supplements Sales 2018-2029 ((K Units)
Figure 17. Global Nicotinamide Riboside Supplements Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Nicotinamide Riboside Supplements Sales YoY (2018-2029) & (K Units)
Figure 19. US & Canada Nicotinamide Riboside Supplements Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Nicotinamide Riboside Supplements Sales YoY (2018-2029) & (K Units)
Figure 21. Europe Nicotinamide Riboside Supplements Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Nicotinamide Riboside Supplements Sales YoY (2018-2029) & (K Units)
Figure 23. China Nicotinamide Riboside Supplements Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Nicotinamide Riboside Supplements Sales YoY (2018-2029) & (K Units)
Figure 25. Asia (excluding China) Nicotinamide Riboside Supplements Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Nicotinamide Riboside Supplements Sales YoY (2018-2029) & (K Units)
Figure 27. Middle East, Africa and Latin America Nicotinamide Riboside Supplements Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Nicotinamide Riboside Supplements Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Nicotinamide Riboside Supplements in the World: Market Share by Nicotinamide Riboside Supplements Revenue in 2022
Figure 30. Global Nicotinamide Riboside Supplements Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Nicotinamide Riboside Supplements Sales Market Share by Type (2018-2029)
Figure 32. Global Nicotinamide Riboside Supplements Revenue Market Share by Type (2018-2029)
Figure 33. Global Nicotinamide Riboside Supplements Sales Market Share by Application (2018-2029)
Figure 34. Global Nicotinamide Riboside Supplements Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Nicotinamide Riboside Supplements Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Nicotinamide Riboside Supplements Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Nicotinamide Riboside Supplements Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Nicotinamide Riboside Supplements Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Nicotinamide Riboside Supplements Revenue Share by Country (2018-2029)
Figure 40. US & Canada Nicotinamide Riboside Supplements Sales Share by Country (2018-2029)
Figure 41. U.S. Nicotinamide Riboside Supplements Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Nicotinamide Riboside Supplements Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Nicotinamide Riboside Supplements Sales Market Share by Type (2018-2029)
Figure 44. Europe Nicotinamide Riboside Supplements Revenue Market Share by Type (2018-2029)
Figure 45. Europe Nicotinamide Riboside Supplements Sales Market Share by Application (2018-2029)
Figure 46. Europe Nicotinamide Riboside Supplements Revenue Market Share by Application (2018-2029)
Figure 47. Europe Nicotinamide Riboside Supplements Revenue Share by Country (2018-2029)
Figure 48. Europe Nicotinamide Riboside Supplements Sales Share by Country (2018-2029)
Figure 49. Germany Nicotinamide Riboside Supplements Revenue (2018-2029) & (US$ Million)
Figure 50. France Nicotinamide Riboside Supplements Revenue (2018-2029) & (US$ Million)
Figure 51. U.K. Nicotinamide Riboside Supplements Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Nicotinamide Riboside Supplements Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Nicotinamide Riboside Supplements Revenue (2018-2029) & (US$ Million)
Figure 54. China Nicotinamide Riboside Supplements Sales Market Share by Type (2018-2029)
Figure 55. China Nicotinamide Riboside Supplements Revenue Market Share by Type (2018-2029)
Figure 56. China Nicotinamide Riboside Supplements Sales Market Share by Application (2018-2029)
Figure 57. China Nicotinamide Riboside Supplements Revenue Market Share by Application (2018-2029)
Figure 58. Asia Nicotinamide Riboside Supplements Sales Market Share by Type (2018-2029)
Figure 59. Asia Nicotinamide Riboside Supplements Revenue Market Share by Type (2018-2029)
Figure 60. Asia Nicotinamide Riboside Supplements Sales Market Share by Application (2018-2029)
Figure 61. Asia Nicotinamide Riboside Supplements Revenue Market Share by Application (2018-2029)
Figure 62. Asia Nicotinamide Riboside Supplements Revenue Share by Region (2018-2029)
Figure 63. Asia Nicotinamide Riboside Supplements Sales Share by Region (2018-2029)
Figure 64. Japan Nicotinamide Riboside Supplements Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Nicotinamide Riboside Supplements Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Nicotinamide Riboside Supplements Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Nicotinamide Riboside Supplements Revenue (2018-2029) & (US$ Million)
Figure 68. India Nicotinamide Riboside Supplements Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Nicotinamide Riboside Supplements Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Nicotinamide Riboside Supplements Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Nicotinamide Riboside Supplements Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Nicotinamide Riboside Supplements Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Nicotinamide Riboside Supplements Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America Nicotinamide Riboside Supplements Sales Share by Country (2018-2029)
Figure 75. Brazil Nicotinamide Riboside Supplements Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico Nicotinamide Riboside Supplements Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey Nicotinamide Riboside Supplements Revenue (2018-2029) & (US$ Million)
Figure 78. Israel Nicotinamide Riboside Supplements Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries Nicotinamide Riboside Supplements Revenue (2018-2029) & (US$ Million)
Figure 80. Nicotinamide Riboside Supplements Value Chain
Figure 81. Nicotinamide Riboside Supplements Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed